Dolutegravir/lamivudine - GSK
At a glance
- Drug Originator GlaxoSmithKline
- Drug Class 3-ring heterocyclic compounds; Amides; Antiretrovirals; Deoxyribonucleosides; Dideoxynucleosides; Oxazines; Pyrimidine nucleosides; Small molecules
- Mechanism of Action HIV integrase inhibitors; Nucleoside reverse transcriptase inhibitors
- USA Patent Applicants VIIV HLTHCARE
- USA Patents 12
- NDAs 1
- International Patents 270
- Patent Applications 49
Table of Contents

Disclaimer